INNOMOL

ENHANCEMENT OF THE INNOVATION POTENTIAL IN SEE THROUGH NEW MOLECULAR SOLUTIONS IN RESEARCH AND DEVELOPMENT

1Closed session

Call Guidelines

This Activity is addressed to highest quality or most promising research entities of significant size (such as University Departments, Faculties, specialised Research Institutes

or important size research laboratories, with at least 10 permanent experienced researchers), established in the eligible regions. These research entities may be qualified

in any S&T field within the scope of EU FP7.

In the proposals, the applicants have to provide evidence of their excellence in research and of their leadership potential in the scientific fields of their competence. They should

include a clear description of their RTD objectives, their main research activities and demonstrate a good track-record of achievements; self-assess their research

accomplishments to demonstrate their potential and expertise; describe the organisation of their entity (who is doing what, short description of available research facilities in

terms of staff and durable equipment); provide short CVs of the most important researchers of their entity, a list of most recent and significant publications or patents,

collaborations with other RTD entities in the country or elsewhere, potential participation in research programmes or activities funded by the European Union, other national or

international organisations or the private sector (SMEs, industry, end-users), etc.

InnoMol – what is it?

Biology MedicineChemistry

Synergy

InnoMol network

11 EU members

1 Associated state

36 Partners

INNOMOL Partners

Bioinformat-ics (6)

Genomics (7)

Proteomics (6)Molecular Interactions

(5)

Transgenics (2)

Bioimaging (10)

INNOMOL – Action plan

Four coherent measuresTwinning through exchange of know-how and experience

Recruitment of experienced researchers

Upgrading, development or acquisition of research equipment

Innovation capacity building

People

EquipmentInnovation

InnoMol – simplified

INNOMOL – goalsFostering a research pipeline at the Ruđer Bošković Institute and facilitating new avenues of innovation and technology for the investigation of relevant diseases

Assemble critical mass of resources and expertises

Bring together and reinforce 3 major worlds of life sciences, e.g. Medicine, Biology, and Chemistry to create a productive, state-of-the-art environment that is unique in the region

Recruitment – reducing the brain drain

Ultimative goal of the project is to find new molecular solutions and new drugs for therapeutic use.

INNOMOL – implementation

Organization of work in workpackages (WP)

7 WP

WP5Dissemination &

Visibility Activities

WP4IPR Management

WP3Equipment Implementation &

Exploitation

WP6Management

WP1Recruitment

Steering committee ofexperts from Partnering

Organizations

WP2Exchange &

Secondments

ProjectManagement board

of 7 WP leaders

Annual meetings

Periodic reports(month 18, 36, 42)

Annual reportMid term reports

Website informationMinutes

News

monthly meetings

CoordinatorAdministrative Management

Finances, IP, Reports, Website,Qualitiy reviews

Advisoryboard

WP7Ex-Post Evaluation

WP6- Managemen

t

Workpackage leaders

Maja Herak Bosnar – Recruitment (WP1)

Marijeta Kralj – Exchange & Secondment (WP2)

Ivo Piantanida – Equipment Implementation & Exploitation (WP3)

Marin Roje – IPR Management (WP4)

Ivanka Jerić – Dissemination & Visibility Activities (WP5)

David Smith – Management (WP6)

Miroslav Plohl – Ex-Post Evaluation (WP7)

+ 3 technicians & 1 administrator

The goal is to hire 7 experienced researchers, to transfer their knowledge and research skills to actual and new staff, and subsequently, to upgrade recruited researchers through secondments and exchange with partnering organizations to become excellent in respective field of expertise.

Focus on returning nationals

Managerial skills

Enhance research

capacities and capabilities of applicant by hiring new

researchers.

Appropriate gender balance

WP 1 - Recruitment

WP2- Secondments

WP3 - Equipment

2.5mil EUR

Available equipmnet

1.4 mil EUR

EC contribution

WP4 – IPR Management

Objectives

• to develop the plan for IP management

• to integrate InnoMol scientific output to the knowledge database of RBI

Recruitment - 1 IP manager

WP5 - Dissemination

Only active participation at the conferences/workshops/seminars/

Round Tables will be supported.

Active participation includes lecture or poster with the most

recent research results or chairmanship of

conference/workshop or session.

WP5 - Dissemination

Co-organise 13th Multinational Congress on Microscopy, 2015.

Epigenomics Congress – International, 2016

WP5 - Dissemination

Staff from RBI will engage in technical organization of 5

workshops(M9, 14, 18, 22, 35)

Lectures for Workshops of secondees from partnering

organizations

WP7- Ex-Post Evaluation

The main task of this WP is to apply for an international independent expert

evaluation of overall RBI research quality and capability (including management

and infrastructure).

The evaluation will take place at the end of the implementation of the Action

Plan.

Budget INNOMOL

Discovernew disease

Nationalfunding

Bilateralfunding

(HR- ISR)

EU fundingspecific for

Croatia(IPA )

EU funding(FP7)

2009.

2010.

2003.

2013.

MSES

EU

State-of-the-Art EnvironmentInnovative infrastructure

New innovation - socioeconomic benefitsChronology

2002.

Initiate newavenues ofresearch

Parallel chronology or universe...

Horizon 2020

Horizon 2020

• Period: 2014-2020Budget: 71 billion (FP7 55 billion)

• The Horizon 2020 programme consists of the following parts:

– “Excellent science” (24 598 million EUR)

– “Industrial leadership” (17 938 million EUR)

– “Societal challenges” (31 748 million EUR)

– In addition, there is a specific programme named „Non-nuclear direct actions of the Joint Research Centre (JRC)” (1962 million EUR).

– http://www.eutrainingsite.com/2014-2020.php?id=106#euf

Horizon 2020

InnoMol Partners

Thank you for your attention!